Vaginal E2 after Breast CA? Yes or No? ACOG CO 659.
Jan 07, 2020•13 min
Episode description
Is vaginal E2 therapy safe in women with a history of breast cancer? What is the data regarding systemic absorption levels? Are you familiar with the recently FDA approved medication IMVEXXY? In the session, we will review the data behind the use of vaginal estrogen and vaginal, non-estrogen therapy for persistent genital atrophy symptoms in women with a current or past history of breast cancer.
For the best experience, listen in Metacast app for iOS or Android
